Contineum Therapeutics
CTNM
#7141
Rank
A$0.77 B
Marketcap
A$20.83
Share price
4.73%
Change (1 day)
241.34%
Change (1 year)

Contineum Therapeutics (CTNM) - Total liabilities

Total liabilities on the balance sheet as of September 2025 : A$14.34 Million

According to Contineum Therapeutics's latest financial reports the company's total liabilities are A$14.34 Million. A companyโ€™s total liabilities is the sum of all current and non-current debts and obligations.

Contineum Therapeutics - Total liabilities on balance sheet (from 2022 to 2025)

Total liabilities by year

Year Total liabilities Change
2024-12-31A$23.76 M-91.84%
2023-12-31A$0.29 B37.71%
2022-12-31A$0.21 B8.37%
2021-12-31A$0.19 B